a public good project by the
Synthesis
Company
of California

© 2026

Daniela Burnes Vargas | doi.page

0 works0 citations0 h-index

Daniela Burnes Vargas

Memorial Sloan Kettering Cancer Center(US)Cornell University(US)Weill Cornell Medicine(US)

Publications by Year

Research Areas

Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Medical Imaging Techniques and Applications, Intraperitoneal and Appendiceal Malignancies, Neuroblastoma Research and Treatments

Most-Cited Works

→ A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy(2020)45 cited
→ Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors - safety at curative doses(2020)44 cited
→ Efficacy of HER2-Targeted Intraperitoneal225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis(2023)19 cited
→ Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis(2021)17 cited
→ Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications(2021)13 cited
→ Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent177Lu-Labeled Radiohapten(2024)10 cited

→ 225 Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2–Expressing Breast Cancer(2025)

3 cited

→ Comparison of targeting two antigens (GPA33 versus HER2) for 225Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer(2025)3 cited

→ Supplementary Data from Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis(2023)

→ Figure S2 from A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy(2023)